Form 8-K - Current report:
SEC Accession No. 0000950170-25-085364
Filing Date
2025-06-12
Accepted
2025-06-12 16:18:45
Documents
10
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K alxo-20250611.htm   iXBRL 8-K 68053
  Complete submission text file 0000950170-25-085364.txt   173119

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alxo-20250611.xsd EX-101.SCH 25860
12 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20250611_htm.xml XML 4537
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 251042796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)